Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444932596
总结
CYP2D6 *4/*4 (assigned as poor metabolizers phenotype) are not associated with decreased Recurrence free survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 (assigned as normal metabolizers phenotype) .